The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses
Open accessAbstract
Interferon (IFN)-I and IFN-II both induce IFN-stimulated gene (ISG) expression through Janus kinase (JAK)-dependent phosphorylation of signal transducer and activator of transcription (STAT) 1 and STAT2. STAT1 homodimers, known as γ-activated factor (GAF), activate transcription in response to all types of IFNs by direct binding to IFN-II activation site (γ-activated sequence)-containing genes. Association of interferon regulatory factor (IRF) 9 with STAT1-STAT2 heterodimers [known as interferon-stimulated gene factor 3 (ISGF3)] or with STAT2 homodimers (STAT2/IRF9) in response to IFN-I, redirects these complexes to a distinct group of target genes harboring the interferon-stimulated response element (ISRE). Similarly, IRF1 regulates expression of ISGs in response to IFN-I and IFN-II by directly binding the ISRE or IRF-responsive element. In addition, evidence is accumulating for an IFN-independent and -dependent role of unphosphorylated STAT1 and STAT2, with or without IRF9, and IRF1 in basal as well as long-term ISG expression. This review provides insight into the existence of an intracellular amplifier circuit regulating ISG expression and controlling long-term cellular responsiveness to IFN-I and IFN-II. The exact timely steps that take place during IFN-activated feedback regulation and the control of ISG transcription and long-term cellular responsiveness to IFN-I and IFN-II is currently not clear. Based on existing literature and our novel data, we predict the existence of a multifaceted intracellular amplifier circuit that depends on unphosphorylated and phosphorylated ISGF3 and GAF complexes and IRF1. In a combinatorial and timely fashion, these complexes mediate prolonged ISG expression and control cellular responsiveness to IFN-I and IFN-II. This proposed intracellular amplifier circuit also provides a molecular explanation for the existing overlap between IFN-I and IFN-II activated ISG expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp, L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W., et al. (2009) · Nature · doi:10.1038/nature07829 · Cited by 2,533
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Brass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154
Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., et al. (2003) · Nature Genetics · doi:10.1038/ng1097 · Cited by 816
9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response
Harismendy, O., Notani, D., Song, X., Rahim, N. G., Tanasa, B., Heintzman, N., Ren, B., Fu, X.-D., Topol, E. J., Rosenfeld, M. G., et al. (2011) · Nature · doi:10.1038/nature09753 · Cited by 611
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype
Toubiana, J., Okada, S., Hiller, J., Oleastro, M., Lagos Gomez, M., Aldave Becerra, J. C., Ouachée-Chardin, M., Fouyssac, F., Girisha, K. M., Etzioni, A., et al. (2016) · Blood · doi:10.1182/blood-2015-11-679902 · Cited by 577
A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain.
Horvath, C. M., Wen, Z., & Darnell, J. E. (1995) · Genes & Development · doi:10.1101/gad.9.8.984 · Cited by 533
Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation
Dupuis, S., Dargemont, C., Fieschi, C., Thomassin, N., Rosenzweig, S., Harris, J., Holland, S. M., Schreiber, R. D., & Casanova, J.-L. (2001) · Science · doi:10.1126/science.1061154 · Cited by 517
Levy, D. E., Kessler, D. S., Pine, R., & Darnell, J. E. (1989) · Genes & Development · doi:10.1101/gad.3.9.1362 · Cited by 469
GAS Elements: A Few Nucleotides with a Major Impact on Cytokine-Induced Gene Expression
DECKER, T., KOVARIK, P., & MEINKE, A. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.121 · Cited by 437
Didcock, L., Young, D. F., Goodbourn, S., & Randall, R. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9928-9933.1999 · Cited by 422
Interferon-Lambda: A New Addition to an Old Family
Donnelly, R. P., & Kotenko, S. V. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0078 · Cited by 420
A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis
He, F., Ge, W., Martinowich, K., Becker-Catania, S., Coskun, V., Zhu, W., Wu, H., Castro, D., Guillemot, F., Fan, G., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1440 · Cited by 397
Cytoplasmic activation of GAF, an IFN-gamma-regulated DNA-binding factor.
Decker, T., Lew, D. J., Mirkovitch, J., & Darnell, J. E. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08026.x · Cited by 374
Pine, R., Canova, A., & Schindler, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06245.x · Cited by 347
Chatterjee-Kishore, M., Wright, K. L., Ting, J. P.-Y., & Stark, G. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4111 · Cited by 346
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
Cheon, H., Holvey-Bates, E. G., Schoggins, J. W., Forster, S., Hertzog, P., Imanaka, N., Rice, C. M., Jackson, M. W., Junk, D. J., & Stark, G. R. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.203 · Cited by 334
Pine, R., Decker, T., Kessler, D. S., Levy, D. E., & Darnell, J. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.6.2448 · Cited by 331
Majoros, A., Platanitis, E., Kernbauer-Hölzl, E., Rosebrock, F., Müller, M., & Decker, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00029 · Cited by 325
Review: On the Role of IRF in Host Defense
Barnes, B., Lubyova, B., & Pitha, P. M. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452665 · Cited by 318
Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes
Cheon, H., & Stark, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903487106 · Cited by 305
Miyashita, M., Oshiumi, H., Matsumoto, M., & Seya, T. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01368-10 · Cited by 303
Harada, H., Takahashi, E., Itoh, S., Harada, K., Hori, T. A., & Taniguchi, T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1500 · Cited by 299
Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
Au-Yeung, N., Mandhana, R., & Horvath, C. M. (2013) · JAK-STAT · doi:10.4161/jkst.23931 · Cited by 296
Fenner, J. E., Starr, R., Cornish, A. L., Zhang, J.-G., Metcalf, D., Schreiber, R. D., Sheehan, K., Hilton, D. J., Alexander, W. S., & Hertzog, P. J. (2006) · Nature Immunology · doi:10.1038/ni1287 · Cited by 293
Lew, D. J., Decker, T., Strehlow, I., & Darnell, J. E. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.182 · Cited by 280
Kröger, A., Köster, M., Schroeder, K., Hauser, H., & Mueller, P. P. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452610 · Cited by 265
STAT2 deficiency and susceptibility to viral illness in humans
Hambleton, S., Goodbourn, S., Young, D. F., Dickinson, P., Mohamad, S. M. B., Valappil, M., McGovern, N., Cant, A. J., Hackett, S. J., Ghazal, P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220098110 · Cited by 255
Kimura, T., Kadokawa, Y., Harada, H., Matsumoto, M., Sato, M., Kashiwazaki, Y., Tarutani, M., Sok‐Pin Tan, R., Takasugi, T., Matsuyama, T., et al. (1996) · Genes to Cells · doi:10.1046/j.1365-2443.1996.08008.x · Cited by 234
Ohtomo, T., Sugamata, Y., Ozaki, Y., Ono, K., Yoshimura, Y., Kawai, S., Koishihara, Y., Ozaki, S., Kosaka, M., Hirano, T., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0683 · Cited by 200
Li, X., Leung, S., Qureshi, S., Darnell, J. E., & Stark, G. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5790 · Cited by 198
Novel STAT1 Alleles in Otherwise Healthy Patients with Mycobacterial Disease
Chapgier, A., Boisson-Dupuis, S., Jouanguy, E., Vogt, G., Feinberg, J., Prochnicka-Chalufour, A., Casrouge, A., Yang, K., Soudais, C., Fieschi, C., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020131 · Cited by 196
Early events in signalling by interferons
Pellegrini, S., & Schindler, C. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90070-4 · Cited by 186
The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses
Błaszczyk, K., Nowicka, H., Kostyrko, K., Antonczyk, A., Wesoły, J., & Bluyssen, H. A. R. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.010 · Cited by 170
Self-citationStudies on the production, mode of action and properties of interferon.
Lindenmann, J.-M., Burke, D. C., & Isaacs, A. (1957) · PubMed · Cited by 169
Qin, H., Roberts, K. L., Niyongere, S. A., Cong, Y., Elson, C. O., & Benveniste, E. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5966 · Cited by 167
DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1
Meyer, T., Marg, A., Lemke, P., Wiesner, B., & Vinkemeier, U. (2003) · Genes & Development · doi:10.1101/gad.268003 · Cited by 161 · cited 9×
“iFn independent IFN independent, basal expression of some ISGs has recently been linked to the nuclear localization of U-ISGF3 and U-GAF (56, 57).”
BackgroundInfluentialItsui, Y., Sakamoto, N., Kakinuma, S., Nakagawa, M., Sekine‐Osajima, Y., Tasaka‐Fujita, M., Nishimura‐Sakurai, Y., Suda, G., Karakama, Y., Mishima, K., et al. (2009) · Hepatology · doi:10.1002/hep.23195 · Cited by 159
ISGF3γ p48, a specificity switch for interferon activated transcription factors
Bluyssen, H. A. R. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00005-6 · Cited by 158
Self-citationHerc5 Attenuates Influenza A Virus by Catalyzing ISGylation of Viral NS1 Protein
Tang, Y., Zhong, G., Zhu, L., Liu, X., Shan, Y., Feng, H., Bu, Z., Chen, H., & Wang, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903588 · Cited by 158
Fink, K., & Grandvaux, N. (2013) · JAK-STAT · doi:10.4161/jkst.27521 · Cited by 157
Banninger, G. P., & Reich, N. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400815200 · Cited by 154
Regulation of LMP2 and TAP1 Genes by IRF-1 Explains the Paucity of CD8+ T Cells in IRF-1−/− Mice
White, L. C., Wright, K. L., Felix, N. J., Ruffner, H., Reis, L. F. L., Pine, R. I., & Ting, J. P. ‐. (1996) · Immunity · doi:10.1016/s1074-7613(00)80262-9 · Cited by 154
Nucleocytoplasmic shuttling of STAT transcription factors
Meyer, T., & Vinkemeier, U. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04423.x · Cited by 153
Decker, T., Lew, D. J., Cheng, Y., Levy, D. E., & Darnell, J. E., Jr. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03608.x · Cited by 151
Reich, N. C. (2013) · JAK-STAT · doi:10.4161/jkst.27080 · Cited by 151
Bluyssen, H. R., & Levy, D. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4600 · Cited by 150
Self-citationIFN-λ4: The Paradoxical New Member of the Interferon Lambda Family
OʼBrien, T. R., Prokunina‐Olsson, L., & Donnelly, R. P. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0136 · Cited by 147
Morris, A. C., Beresford, G., Mooney, M. R., & Boss, J. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4781-4791.2002 · Cited by 145
Dynamic Trans-Acting Factor Co-localization in Human Cells
Xie, D., Boyle, A., Wu, L., Zhai, J., Kawli, T., & Snyder, M. (2013) · Cell · doi:10.1016/j.cell.2013.09.043 · Cited by 144
Getting the message across, STAT! Design principles of a molecular signaling circuit
Vinkemeier, U. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200407163 · Cited by 137
Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon
Dong, B., Zhou, Q., Zhao, J., Zhou, A., Harty, R. N., Bose, S., Banerjee, A. K., Slee, R. B., Guenther-Johnson, J. M., Williams, B. R. G., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.17.8983-8993.2004 · Cited by 135
Ramsauer, K., Farlik, M., Zupkovitz, G., Seiser, C., Kröger, A., Häuser, H., & Decker, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610944104 · Cited by 124
Global changes in STAT target selection and transcription regulation upon interferon treatments
Hartman, S. E., Bertone, P., Nath, A. K., Royce, T. E., Gerstein, M., Weissman, S. M., & Snyder, M. P. (2005) · Genes & Development · doi:10.1101/gad.1371305 · Cited by 123
STAT activation and differential complex formation dictate selectivity of interferon responses.
Wesoły, J., Szweykowska-Kulińska, Z., & Bluyssen, H. A. R. (2007) · Acta Biochimica Polonica · doi:10.18388/abp.2007_3266 · Cited by 121
Self-citationKraus, T., Lau, J. F., Parisien, J.-P., & Horvath, C. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212972200 · Cited by 112
Ni, Z., Hassan, M. A. E., Xu, Z., Tao, Y., & Bremner, R. (2008) · Nature Immunology · doi:10.1038/ni.1619 · Cited by 112
Błaszczyk, K., Olejnik, A., Nowicka, H., Ozgyin, L., Chen, Y., Chmielewski, S., Kostyrko, K., Wesoły, J., Bálint, B. L., Lee, C., et al. (2015) · Biochemical Journal · doi:10.1042/bj20140644 · Cited by 109
Self-citationFunctional domains of interferon regulatory factor I (IRF-1)
Schaper, F., KIRCHHOFF, S., Posern, G., Köster, M., Oumard, A., Sharf, R., Levi, B.-Z., & Häuser, H. (1998) · Biochemical Journal · doi:10.1042/bj3350147 · Cited by 106
STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling
Begitt, A., Droescher, M., Meyer, T., Schmid, C. D., Baker, M., Antunes, F., Knobeloch, K., Owen, M. R., Naumann, R., Decker, T., et al. (2014) · Nature Immunology · doi:10.1038/ni.2794 · Cited by 104
Isolation and Characterization of a Human STAT1Gene Regulatory Element
Wong, L. H., Sim, H., Chatterjee‐Kishore, M., Hatzinisiriou, I., Devenish, R. J., Stark, G. R., & Ralph, S. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111302200 · Cited by 95
Gongora, C., Degols, G., Espert, L., Hua, T. D., & Mechti, N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.12.2333 · Cited by 94
Wang, W., Yin, Y., Xu, L., Su, J., Huang, F., Wang, Y., Boor, P. P. C., Chen, K., Wang, W., Cao, W., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aah4248 · Cited by 93
Sendai virus C protein physically associates with Stat1
Takeuchi, K., Komatsu, T., Yokoo, J., Kato, A., Shioda, T., Nagai, Y., & Gotoh, B. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00442.x · Cited by 90
IFN-α Activates Stat6 and Leads to the Formation of Stat2:Stat6 Complexes in B Cells
Gupta, S. K., Jiang, M., & Pernis, A. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3834 · Cited by 89
A novel kindred with inherited STAT2 deficiency and severe viral illness
Moens, L., Eyck, L. V., Jochmans, D., Mitera, T., Frans, G., Bossuyt, X., Matthys, P., Neyts, J. H., Ciancanelli, M. J., Zhang, S., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.10.033 · Cited by 87
IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells.
Gupta, S. K., Jiang, M., & Pernis, A. B. (1999) · PubMed · Cited by 84
Viral Induction of the Zinc Finger Antiviral Protein Is IRF3-dependent but NF-κB-independent
Wang, N., Dong, Q., Li, J., Jangra, R. K., Fan, M., Brasier, A. R., Lemon, S. M., Pfeffer, L. M., & Li, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054486 · Cited by 84
STAT2 phosphorylation and signaling
Steen, H. C., & Gamero, A. M. (2013) · JAK-STAT · doi:10.4161/jkst.25790 · Cited by 84
Ronni, T., Matikainen, S., Lehtonen, A., Palvimo, J. J., DELLIS, J., Eylen, F. V., Goetschy, J., Horisberger, M. A., Content, J., & Julkunen, I. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.773 · Cited by 82
Schmeisser, H., Mejido, J., Balinsky, C. A., Morrow, A., Clark, C. R., Zhao, T., & Zoon, K. C. (2010) · Journal of Virology · doi:10.1128/jvi.00818-10 · Cited by 81
Tan, J., Qiao, W., Wang, J., Xu, F., Li, Y., Zhou, J., Chen, Q., & Geng, Y. (2008) · Journal of Virology · doi:10.1128/jvi.02249-07 · Cited by 79
Haque, S. J., & Williams, B. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32200-7 · Cited by 77
Ogony, J. W., Choi, H. J., Lui, A. J., Cristofanilli, M., & Lewis-Wambi, J. S. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0683-7 · Cited by 77
A Novel STAT1 Mutation Associated with Disseminated Mycobacterial Disease
Sampaio, E. P., Bax, H. I., Hsu, A. P., Kristosturyan, E., Pechacek, J., Chandrasekaran, P., Paulson, M. L., Dias, D. L., Spalding, C. D., Uzel, G., et al. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9659-2 · Cited by 75
Morrow, A., Schmeisser, H., Tsuno, T., & Zoon, K. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001359 · Cited by 74
Paramyxovirus Disruption of Interferon Signal Transduction: STATus Report
Ramachandran, A., & Horvath, C. M. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0070 · Cited by 73
Lou, Y., Pan, X., Jia, P.-M., Li, D., Shu Dong, X. I. A. O., Zhang, Z., Chen, S., Zhu, C. H., & Tong, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4922 · Cited by 73
Transcription factors induced by interferons α and γ
Imam, A., Ackrill, A. M., Dale, T. C., Kerr, I. M., & Stark, G. R. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.22.6573 · Cited by 72
Cooperation of STAT-1 and IRF-1 in Interferon-γ-induced Transcription of the gp91 Gene
Kumatori, A., Yang, D., Suzuki, S., & Nakamura, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109803200 · Cited by 71
Ghislain, J. J., & Fish, E. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12408 · Cited by 71
A ChIP–chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response
Frontini, M., Vijayakumar, M., Garvin, A. J., & Clarke, N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1051 · Cited by 69
Ghislain, J. J., Wong, T. S.-H., Nguyen, M. H.-H., & Fish, E. N. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001750277853 · Cited by 66
Testoni, B., Voellenkle, C., Guerrieri, F., Gerbal‐Chaloin, S., Blandino, G., & Levrero, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231068 · Cited by 64
Xu, L., Zhou, X., Wang, W., Wang, Y., Yin, Y., van der Laan, L. J. W., Sprengers, D., Metselaar, H. J., Peppelenbosch, M. P., & Pan, Q. (2016) · The FASEB Journal · doi:10.1096/fj.201600356r · Cited by 63
The genomic structure of the STAT genes: multiple exons in coincident sites in Stat1 and Stat2
Yan, R., Qureshi, S. A., Zhong, Z., Wen, Z., & Darnell, J. E., Jr. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.3.459 · Cited by 59
Stewart, M., Choi, Y., Johnson, G., Yu-Lee, L., Bazer, F., & Spencer, T. E. (2002) · Biology of Reproduction · doi:10.1095/biolreprod66.2.393 · Cited by 59
Bluyssen, H. A. R., Vlietstra, R. J., Faber, P. W., Smit, E. M. E., Hagemeijer, A., & Trapman, J. (1994) · Genomics · doi:10.1006/geno.1994.1591 · Cited by 58
Self-citationMegger, D. A., Philipp, J., Le‐Trilling, V. T. K., Sitek, B., & Trilling, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01139 · Cited by 58
Properties of STAT1 and IRF1 enhancers and the influence of SNPs
Hassan, M. A. E., Huang, K., Eswara, M. B. K., Xu, Z., Tao, Y., Aubry, A., Ni, Z., Livne-Bar, I., Sangwan, M., Ahmad, M. S., et al. (2017) · BMC Molecular Biology · doi:10.1186/s12867-017-0084-1 · Cited by 50
Genome-wide analysis of interferon regulatory factor I binding in primary human monocytes
Shi, L., Perin, J. C., Leipzig, J. N., Zhang, Z., & Sullivan, K. E. (2011) · Gene · doi:10.1016/j.gene.2011.07.004 · Cited by 47
Wang, M., Pober, J. S., & Johnson, D. R. (1998) · Circulation Research · doi:10.1161/01.res.83.8.815 · Cited by 47
Yao, K., Chen, Q., Wu, Y., Liu, F., Chen, X., & Zhang, Y. (2017) · Journal of Cell Science · doi:10.1242/jcs.200659 · Cited by 47
Yamauchi, S., Takeuchi, K., Chihara, K., Honjoh, C., Kato, Y., Yoshiki, H., Hotta, H., & Sada, K. (2016) · Scientific Reports · doi:10.1038/srep38336 · Cited by 43
Parrington, J., Rogers, N. C., Gewert, D. R., Pine, R. I., Veals, S. A., Levy, D. E., Stark, G. R., & Kerr, I. M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17961.x · Cited by 40
Tessitore, A., Pastore, L., Rispoli, A., Cilenti, L., Toniato, E., Flati, V., Farina, A. R., Frati, L., Gulino, A., & Martinotti, S. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2580968.x · Cited by 39
Yuasa, K., & Hijikata, T. (2015) · Genes to Cells · doi:10.1111/gtc.12316 · Cited by 39
Trilling, M., Bellora, N., Rutkowski, A. J., de Graaf, M., Dickinson, P., Robertson, K. A., da Costa, O. P., Ghazal, P., Friedel, C. C., Albà, M. M., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt589 · Cited by 37
Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs
Sater, A. A. A., Majoros, A., Plumlee, C. R., Perry, S. T., Gu, A.-D., Lee, C., Shresta, S., Decker, T., & Schindler, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401139 · Cited by 36
Characterization of the Gene Encoding the 100-kDa Form of Human 2′,5′Oligoadenylate Synthetase
Rebouillat, D., Hovnanian, A., David, G., et al. (2000) · Genomics · doi:10.1006/geno.2000.6382 · Cited by 36
Regulation of the innate immune system by ubiquitin and ubiquitin-like modifiers
Oudshoorn, D., Versteeg, G. A., & Kikkert, M. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.08.003 · Cited by 33
Functional Relevance of the Conserved DNA-binding Domain of STAT2
Brierley, M. M., & Fish, E. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500426200 · Cited by 32
Brierley, M. M., Marchington, K. L., Jurišica, I., & Fish, E. N. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05176.x · Cited by 30
Clarke, A. R. N. M. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s6-009 · Cited by 29
The Role of Signal Transducer and Activator of Transcription-2 in the Interferon Response
Steen, H. C., & Gamero, A. M. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0099 · Cited by 28
Wang, Q., & Floyd-Smith, G. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.1385 · Cited by 26
A rapid simple approach to quantify chromosome conformation capture
Hassan, M. A. E., & Bremner, R. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp028 · Cited by 23
Li, P., Shi, M., Shen, W., Zhang, Z., Xie, D., Zhang, X.-Y., He, C., Zhang, Y., & Zhao, Z. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.05.003 · Cited by 19
Interferon-γ Upregulates Expression of IFP35 Gene in HeLa Cells via Interferon Regulatory Factor-1
Yang, W., Tan, J., Liu, R., Cui, X., Ma, Q., Geng, Y., & Qiao, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050932 · Cited by 16
REST Negatively and ISGF3 Positively Regulate the Human STAT1 Gene in Melanoma
Amalraj, J., Cutler, S. J., Ghazawi, I., Boyle, G. M., & Ralph, S. J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0923 · Cited by 15
Yuasa, K., Takeda, S., & Hijikata, T. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.074 · Cited by 10
Cited by
Multiple early factors anticipate post-acute COVID-19 sequelae
Su, Y., Yuan, D., Chen, D. G., Ng, R. H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.014 · Cited by 1,156
“5) implied enhanced BCR and IFN signaling (Michalska et al., 2018), reminiscent of the hyperactive state of B cells seen in SLE (Domeier et al., 2018), and associated with the over-production of lupus autoAbs (Jenks et al., 2018).”
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Owen, K. L., Brockwell, N. K., & Parker, B. S. (2019) · Cancers · doi:10.3390/cancers11122002 · Cited by 714
Decoding type I and III interferon signalling during viral infection
Mesev, E. V., LeDesma, R. A., & Ploss, A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0421-x · Cited by 538
Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases
Ota, M., Nagafuchi, Y., Hatano, H., Ishigaki, K., Terao, C., Takeshima, Y., Yanaoka, H., Kobayashi, S., Okubo, M., Shirai, H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.056 · Cited by 331
Global absence and targeting of protective immune states in severe COVID-19
Combes, A. J., Courau, T., Kuhn, N. F., Hu, K. H., Ray, A., Chen, W. S., Chew, N. W., Cleary, S. J., Kushnoor, D., Reeder, G. C., et al. (2021) · Nature · doi:10.1038/s41586-021-03234-7 · Cited by 256
Metadata
- Authors
- Michalska, A., Blaszczyk, K., Wesoly, J., & Bluyssen, H. A. R.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2018-05-28
- Volume
- 9
- Pages
- 1135-1135
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2801894898
- Cited by
- 322
- References
- 123
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.